Rare diseases
Investigational molecules
Locations
444 West Lake Street Suite 1700, 60606-0070, United States
Maia Biotechnology Inc. focuses its clinical research on advanced and metastatic non-small cell lung cancer, with interest in later-line treatment settings and outcomes for patients whose disease has progressed after prior therapy.
The sponsor’s oncology portfolio centers on evaluating therapeutic options for lung cancer patients needing additional disease control, with emphasis on survival benefit, efficacy, and tolerability in difficult-to-treat disease.
Maia Biotechnology Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage III, Non-small cell lung cancer stage IV, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Hungary
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
